Intravenous beta-adrenoblocker therapy in acute coronary syndrome patients

Early treatment optimization improves clinical outcomes and reduces morbidity and mortality in patients with acute myocardial infarction (AMI). Intravenous beta-adrenoblocker (BAB) therapy, associated with improved survival, is well tolerated by AMI patients. The results of relevant clinical trials...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: S. N. Tereshchenko, I. V. Zhirov
Materyal Türü: Artigo
Dil:Russo
Baskı/Yayın Bilgisi: «SILICEA-POLIGRAF» LLC 1970-01-01
Seri Bilgileri:Кардиоваскулярная терапия и профилактика
Konular:
acute myocardial infarction
beta-adrenoblockers
cardiogenic shock
genetic polymorphism
Online Erişim:https://cardiovascular.elpub.ru/jour/article/view/1497
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller